Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Santarus, Inc. (NASDAQ:SNTS) 21 0 0
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) 4 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 15 0 0
ImmunoGen, Inc. (NASDAQ:IMGN) 4 0 0
Acorda Therapeutics Inc (NASDAQ:ACOR) 12 0 0

Using the results explained by Insider Monkey’s research, regular investors must always keep one eye on hedge fund and insider trading sentiment, and Nektar Therapeutics (NASDAQ:NKTR) is an important part of this process.

Discover how hedge fund piggybacking can benefit you

Recommended Reading:

Nektar Therapeutics (NKTR): A Pain Management Play That You Should Explore

Nektar Therapeutics (NKTR), Stemline Therapeutics Inc (STML): Humongous Health-Care Stocks This Week

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Page 2 of 2